Year: 2026

Schouw & Co. share buy-back programme, week 13 2026

Written by Customer Service on March 30, 2026. Posted in Mergers And Acquisitions.

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK Accumulated until 20 March 2026 96,283 670.79 64,585,477 Monday, 23 March 2026 1,000 593.00 593,000 Tuesday, 24 March 2026 1,000 622.00 622,000 Wednesday, 25 March 2026 1,000 642.00 642,000 Thursday, 26 March 2026 1,000 638.80 638,804 Friday,...

Willis Lease Finance Corporation Amends Revolving Credit Facility

Written by Customer Service on March 30, 2026. Posted in Public Companies.

COCONUT CREEK, Fla., March 30, 2026 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and a global provider of aviation services, today announced that it has amended and extended its existing revolving credit facility, increasing total commitments from $1.0 billion to $1.75 billion and extending the maturity to April of 2031. The amended facility was oversubscribed, with approximately $1.0 billion in excess lender commitments, reflecting strong support from the Company’s lenders/partners. “We are very pleased to complete the expansion and extension of our revolving credit facility, reflecting the strength and confidence the markets have in our platform,” said Scott B. Flaherty, EVP & Chief Financial Officer of Willis Lease Finance...

Volaris Group Acquires zetVisions GmbH, Strengthening Its Position in the Legal Entity Management Software Market

Written by Customer Service on March 30, 2026. Posted in Mergers And Acquisitions.

TORONTO, March 30, 2026 (GLOBE NEWSWIRE) — Volaris Group today announced the acquisition of zetVisions GmbH, a leading German software provider for enterprise equity and master data management. This further expands Volaris Group’s German portfolio in a high-growth segment. The company and its shareholders were advised by Marks Baughan Securities, London. zetVisions GmbH is a specialized software provider headquartered in Heidelberg, Germany. For over 20 years, the company has been developing and implementing solutions that provide structured oversight, maintenance, and compliance for corporate entities across global jurisdictions. Its customers include numerous publicly listed companies, medium-sized businesses, and public sector entities. Based on more than 400 successfully completed projects across various industries, zetVisions...

Arax Investment Partners Adds Omni Financial Advisory Group

Written by Customer Service on March 30, 2026. Posted in Mergers And Acquisitions.

NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) — Arax Investment Partners (“Arax”), a national wealth management company, today announced that it has acquired Omni Financial Advisory Group (“Omni Financial”), a boutique financial advisory practice headquartered in Poughkeepsie, New York. Founded by Gregory Bayer more than 30 years ago and built as a multi-generational family practice, Omni Financial has earned a reputation for delivering highly personalized investment management and financial planning to high-net-worth individuals and families. Today, Gregory is joined by his son, Braedon, CFP® practitioner, and daughter, Reilly, Client Service Coordinator. The Bayer family works together to ensure that clients benefit from the relationship-focused approach that has proven impactful over decades, while infusing their advisory practice...

Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Written by Customer Service on March 30, 2026. Posted in Earnings Releases And Operating Results.

First patient dosed in UPSTREAM SjD, a global Phase 3 clinical trial assessing telitacicept in primary Sjögren’s disease $75 million private placement strengthens balance sheet and supports telitacicept global clinical development Pro-forma cash and investment balance of $530.2 million as of December 31, 2025 expected to provide runway into early 2029 BOSTON, March 30, 2026 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a corporate update. “Over the past six months, Vor Bio repositioned the company around telitacicept and moved quickly to build momentum. We are seeing strong engagement from key opinion leaders and principal investigators,...

Standard Lithium Reports Fourth Quarter and Full Year 2025 Results

Written by Customer Service on March 30, 2026. Posted in Earnings Releases And Operating Results.

Signed First Binding Customer Offtake Agreement with Trafigura Received Indications of Interest for Over $1 Billion in Project Finance Provides an Update on Plans for a Final Investment Decision (“FID”) on the South West Arkansas Project (the “SWA Project”)VANCOUVER, British Columbia, March 30, 2026 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, today announced its financial and operating results for the three-month and full year periods ended December 31, 2025. “We had a busy and productive fourth quarter as we advanced and completed multiple important milestones and deliverables for the Company,” said David Park, Chief Executive Officer and Director of Standard Lithium. “We filed a positive Definitive Feasibility Study for...

Rezolve Ai Delivers 543% H2 Growth; Raises 2026 Revenue Guidance to $360M as Platform Achieves Global Infrastructure Scale

Written by Customer Service on March 30, 2026. Posted in Earnings Releases And Operating Results.

Reports $46.8M Revenue for 2025 materially ahead of market expectations Exits 2025 at $232M ARR1 with $19.4M December MRR1 Contracted Revenue1 Underpins 2026 Growth Trajectory FY 2026 revenue guidance raised to $360 million; Reiterated 2026 exit ARR1 of $500 million NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a global leader in Agentic Commerce and AI-powered retail infrastructure, today announced its full-year 2025 results, delivering performance materially ahead of market expectations and moving the business into live, scaled global deployment. Record Revenue: Reported GAAP revenue of $46.8 million for the year. Explosive Exit Velocity: Exited 2025 with a record $19.4M December MRR, representing a $232M+ Annualized Run Rate (ARR), exceeding original guidance of $100 million. Structural Profitability:...

Nano Labs Announces Second Half of 2025 Financial Results

Written by Customer Service on March 30, 2026. Posted in Earnings Releases And Operating Results.

HANGZHOU, China, March 30, 2026 (GLOBE NEWSWIRE) — Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider and crypto treasury company today announced its unaudited financial results as of December 31, 2025 and for the six months ended December 31, 2025. Second Half of 2025 Financial SummaryNet revenue increased by 18.1% to RMB18.7 million (US$2.7 million) for the second half of 2025, from RMB15.9 million in the same period of 2024. Gross loss was RMB29.1 million (US$4.1 million) for the second half of 2025, compared to a gross profit of RMB11.6 million in the same period of 2024. Gain on change in fair value of cryptocurrencies was RMB130.0 million (US$18.5 million) for the second half of 2025, compared to a loss of RMB15.7 million in the same period of 2024. Profit...

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

Written by Customer Service on March 30, 2026. Posted in Public Companies.

Results from pediatric patients in the SAVE Registry shows no device-related adverse events or immunosuppression and continued strong survival data In vitro analysis of the SeaStar Medical SCD indicates modulation of the immune response, shifting monocytes towards an anti-inflammatory, reparative phenotype SeaStar Medical hosts an industry symposium and panel discussion focused on innovation in the treatment of pediatric AKI, supporting its emerging leadership in this community DENVER, March 30, 2026 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today the presentations of new SAVE Registry data and investigator led research on the mechanism of action...

YY Group Holding (NASDAQ: YYGH) Pauses At-The-Market Offering

Written by Customer Service on March 30, 2026. Posted in Public Companies.

Company Confirms Sufficient Liquidity to Execute FY2026 Growth Plan; Related Share Cancellation to Reduce Outstanding Shares to 3,274,828 Singapore, March 30, 2026 (GLOBE NEWSWIRE) — YY Group Holding Limited (NASDAQ: YYGH) (“YY Group” or the “Company”), a global leader in on-demand workforce solutions and integrated facilities management (IFM), today announced that it has instructed its sales agents, Spartan Capital Securities, LLC and Wilson-Davis & Co., Inc., to pause the Company’s At-The-Market (“ATM”) equity offering program, effective immediately. In connection with the pause, the Company has directed the return and cancellation of 1,004,107 shares of common stock that were allocated to the sales agents but were not offered or sold into the market. Upon completion of the cancellation process, total shares...

Year: 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals